Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Carbetocin vs Tranexamic Acid for Reducing Blood Loss During Myomectomy
TCTR20260626006Phase 2Not yet recruiting
- Sponsor
- Rajavithi Hospital
- Start
- Jun 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carbetocin, tranexamic acid in Fibromyoma (LM), sponsored by Rajavithi Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
carbetocintranexamic acid
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on TCTR20260626006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260626006.